Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;68(3):353-68.
doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30.

The role of HLA-G in immunity and hematopoiesis

Edgardo D Carosella  1 , Silvia Gregori, Nathalie Rouas-Freiss, Joel LeMaoult, Catherine Menier, Benoit Favier
Affiliations
Review

The role of HLA-G in immunity and hematopoiesis

Edgardo D Carosella et al. Cell Mol Life Sci. 2011 Feb.

Abstract

The non-classical HLA class I molecule HLA-G was initially shown to play a major role in feto-maternal tolerance. Since this discovery, it has been established that HLA-G is a tolerogenic molecule which participates to the control of the immune response. In this review, we summarize the recent advances on (1) the multiple structures of HLA-G, which are closely associated with their role in the inhibition of NK cell cytotoxicity, (2) the factors that regulate the expression of HLA-G and its receptors, (3) the mechanism of action of HLA-G at the immunological synapse and through trogocytosis, and (4) the generation of suppressive cells through HLA-G. Moreover, we also review recent findings on the non-immunological functions of HLA-G in erythropoiesis and angiogenesis.

PubMed Disclaimer

References

    1. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA. 1997;94:11520–11525. doi: 10.1073/pnas.94.21.11520. - DOI - PMC - PubMed
    1. Carosella ED, Rouas-Freiss N, Paul P, Dausset J. HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol Today. 1999;20:60–62. doi: 10.1016/S0167-5699(98)01387-5. - DOI - PubMed
    1. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol. 2008;29:125–132. doi: 10.1016/j.it.2007.11.005. - DOI - PubMed
    1. Menier C, Rouas-Freiss N, Favier B, Lemaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens. 2010;75:201–206. - PubMed
    1. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the Ig superfamily. Eur J Immunol. 1998;28:1980–1990. doi: 10.1002/(SICI)1521-4141(199806)28:06<1980::AID-IMMU1980>3.0.CO;2-F. - DOI - PubMed

Publication types

MeSH terms